Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Douglas Middleton Dahl, M.D.

Co-Author

This page shows the publications co-authored by Douglas Dahl and Mark Preston.
Connection Strength

0.414
  1. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol. 2016 08 10; 34(23):2705-11.
    View in: PubMed
    Score: 0.166
  2. Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urol Oncol. 2015 Sep; 33(9):383.e9-16.
    View in: PubMed
    Score: 0.155
  3. Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years. J Urol. 2019 04; 201(4):721-727.
    View in: PubMed
    Score: 0.051
  4. Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance. AJR Am J Roentgenol. 2016 Oct; 207(4):789-796.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.